We were told there would be data cuts done for major conferences...

We were told there would be data cuts done for major conferences and there was a data cut in December which went into the abstract; just as we were told would happen.

What we all hope for is that there was another more recent data cut done for the poster presentation which won’t be released to the ASX until Wednesday morning. Until then we don’t know either way so there’s no need to start second guessing before then. However, if there is not updated data for the poster then the fact still remains, they did do a data cut for the conference so really, no one can say nor complain that it didn’t happen.

Neither YF or LC were involved in writing the paper so, I don’t know why anyone would expect either of them to be involved in the presentation at the AACR conference. People need to differentiate between the various roles. Yes, YF initially developed Vaxinia but he’s not actually running the clinical trials. Yes, LC is the Managing Director/CEO of Imugene but she isn’t actually running the clinical trials. The doctors at the hospitals and some support staff within Imugene are the ones with the hands on involvement with the trials and responsible for collecting, collating, analysing and writing up the results of there findings so, it only makes sense that one or more of them would be the ones presenting the findings at medical conferences. However, if CF33 does become the super star most of us hope it does, then for sure it will be YF fronting up to the media to tell the world about what he invented followed by LC telling the world it’s owned by Imugene, because that’s where their roles fit within the big picture.